Viable: yes, no, or somewhere in the middle?

JACC Cardiovasc Imaging. 2009 Sep;2(9):1069-71. doi: 10.1016/j.jcmg.2009.06.005.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Coronary Artery Disease / complications
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / therapy*
  • Fluorodeoxyglucose F18
  • Humans
  • Magnetic Resonance Imaging
  • Myocardial Infarction / etiology
  • Myocardial Infarction / mortality
  • Myocardial Revascularization* / adverse effects
  • Myocardial Revascularization* / mortality
  • Myocardial Stunning / diagnostic imaging
  • Myocardial Stunning / etiology*
  • Myocardial Stunning / mortality
  • Myocardium / pathology*
  • Patient Selection
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Radiopharmaceuticals
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Tissue Survival
  • Treatment Outcome
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / mortality

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18